Rates of immunization against pandemic and seasonal influenza in persons at high risk of severe influenza illness: a cross-sectional study among patients of the French Sentinelles general practitioners

BMC Public Health

Solen Kernéis³  Thomas Hanslik³  Laure Fonteneau¹  Clément Turbelin³  Cécile Souty³  Marie-Lise Grisoni³  Alessandra Falchi²  Ludivine Privileggio³ 

[1] Département des Maladies Infectieuses, Institut de Veille Sanitaire, Saint-Maurice, France;Laboratoire de Virologie, Université de Corse, France;UPMC Université Paris 06, UMR-S U707, Paris, F-75012, France

关键词: Obesity;    Pregnancy;    Sentinelles network;    General practitioners;    Influenza;    Vaccination;   

Others  :  1162434
DOI  :  10.1186/1471-2458-13-246

 received in 2012-10-26, accepted in 2013-03-11,  发布年份 2013

【 摘 要 】

Background

Three main categories of persons are targeted by the French influenza vaccination strategy: all persons aged 65 years or over, those aged less than 65 years with certain underlying medical conditions and health care workers. The main objective of this study was to estimate rates of influenza immunization in these target groups attending a medical consultation for two consecutive influenza seasons: 2009–2010 (seasonal and pandemic vaccines) and 2010–2011 (seasonal vaccine).

Methods

A standardized questionnaire was mailed to 1323 general practitioners (GPs) of the Sentinelles Network, collecting data on all patients seen on a randomly assigned day. For every patient, following information was collected: age, gender, BMI, presence of any medical condition that increases risk of severe influenza illness, and vaccination status for the three vaccines mentioned.

Results

Two hundred and three GPs agreed to participate and included 4248 patients. Overall, in persons with high risk of severe influenza, the estimated vaccine coverages (VC) were 60%, (95% CI = 57%; 62%) for the seasonal vaccine in 2010–2011, 61% (59%; 63%) for the seasonal vaccine in 2009–2010 and 23% (21%; 25%), for the pandemic vaccine in 2009–2010. Among people aged 65 years and over (N=1259, 30%) VC was estimated for seasonal vaccines at 72% (70%; 75%) in 2010–2011 and 73% (71%; 76%) in 2009–2010, and 24% (22%; 26%) for the pandemic vaccine. The lowest seasonal VC were observed in younger persons (<65 years) with underlying medical conditions, in particular pregnant women (<10%) and overweight persons (<30%).

Conclusions

Our study shows that influenza vaccination coverage among patients of the French Sentinelles general practitioners remains largely below the target of 75% defined by the 2004 French Public Health Law, and underscores the need for the implementation of public health interventions likely to increase vaccination uptake.

【 授权许可】

   
2013 Privileggio et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Mereckiene J, Cotter S, D'Ancona F, Giambi C, Nicoll A, Lévy-Bruhl D, Lopalco PL, Weber JT, Johansen K, Dematte L, Salmaso S, Stefanoff P, Greco D, Dorleans F, Polkowska A, O’Flanagan D, on behalf of the VENICE project gatekeepers group: Differences in national influenza vaccination policies across the European Union, Norway and Iceland 2008-2009. Euro Surveill 2010, 15:pii=19700.
• [2]Institut de Veille Sanitaire: Calendrier des vaccinations et recommandations vaccinales 2009 selon l’avis du Haut conseil de la santé publique. BEH 2009, 16-17:148-149. http://www.invs.sante.fr/beh/2009/16_17/beh_16_17_2009.pdf webcite
• [3]Haut Conseil de Santé Publique: Avis relatif à l’actualisation de la stratégie vaccinale contre la grippe 2010–2011. 2010, 9. http://www.hcsp.fr/docspdf/avisrapports/hcspa20101229_actuavacgrippe.pdf webcite
• [4]Tuppin P, Samson S, Weill A, Ricordeau P, Allemand H: Seasonal influenza vaccination coverage in France during two influenza seasons (2007 and 2008) and during a context of pandemic influenza A(H1N1) in 2009. Vaccine 2011, 29:4632-4637.
• [5]Flahault A, Blanchon T, Dorléans Y, Toubiana L, Vibert JF, Valleron AJ: Virtual surveillance of communicable diseases: a 20-year experience in France. Stat Methods Med Res 2006, 15:413-421.
• [6]Institut national de la statistique et des études économiques: Définitions et méthodes. http://www.insee.fr/fr/methodes/default.asp?page=definitions/unite-urbaine.htm webcite
• [7]Institut national de prévention et d'éducation pour la santé: Baromètre santé médecins généralistes. 2009. http://www.inpes.sante.fr/CFESBases/catalogue/pdf/1343.pdf webcite
• [8]Hanslik T, Espinoza P, Boelle PY, Cantin-Bertaux D, Gallichon B, Quendez S, Aïm JL, Retel O, Ballereau M, Gorodetzky N, Flahault A: Sentinel monitoring of general community health during the 1998 World Football Cup. Rev Epidemiol Sante Publique 2001, 49:135-145.
• [9]Tuppin P, Choukroun S, Samson S, Weill A, Ricordeau P, Allemand H: Vaccination against seasonal influenza in France in 2010 and 2011: Decrease of coverage rates and associated factors. Presse Med 2012 Nov, 41(11):e568-76.
• [10]Delelis-Fanien A-S, Séité F, Priner M, Paccalin M: Vaccine coverage against influenza and pneumococcal infections in patients aged 65 and over: a survey on 299 outpatients. Rev Med Interne 2009, 30:656-660.
• [11]Guthmann J-P, Fonteneau L, Bonmarin I, Lévy-Bruhl D: Influenza vaccination coverage one year after the A(H1N1) influenza pandemic, France, 2010–2011. Vaccine 2012, 30:995-997.
• [12]Aguilar I, Reyes M, Martínez-Baz I, Guevara M, Albéniz E, Belza MJ, Castilla J: Use of the vaccination register to evaluate influenza vaccine coverage in seniors in the 2010/11 influenza season, Navarre, Spain. Euro Surveill 2012, 17:pii=20154.
• [13]Takayama M, Wetmore CM, Mokdad AH: Characteristics associated with the uptake of influenza vaccination among adults in the United States. Prev Med 2012, 54:358-362.
• [14]Jiménez-García R, Hernández-Barrera V, Carrasco Garrido P, del Pozo SV-F, de Miguel AG: Influenza vaccination among cardiovascular disease sufferers in Spain: related factors and trend, 1993–2003. Vaccine 2006, 24:5073-5082.
• [15]Singleton JA, Wortley P, Lu P-J: Influenza vaccination of persons with cardiovascular disease in the United States. Tex Heart Inst J 2004, 31:22-27.
• [16]Mayo Montero E, Hernández Barrera V, Carrasco Garrido P, Gil De Miguel A, Jiménez García R: Influenza vaccination among persons with chronic respiratory diseases: coverage, related factors and time-trend, 1993–2001. Public Health 2007, 121:113-121.
• [17]Chiatti C, Barbadoro P, Marigliano A, Ricciardi A, Di Stanislao F, Prospero E: Determinants of influenza vaccination among the adult and older Italian population with chronic obstructive pulmonary disease: a secondary analysis of the multipurpose ISTAT survey on health and health care use. Hum Vaccin 2011, 7:1021-1025.
• [18]Jiménez-García R, Ariñez-Fernandez MC, Garcia-Carballo M, Hernández-Barrera V, de Miguel AG, Carrasco-Garrido P: Influenza vaccination coverage and related factors among Spanish patients with chronic obstructive pulmonary disease. Vaccine 2005, 23:3679-3686.
• [19]Jiménez-García R, Jimenez I, Garrido PC, Hernández-Barrera V, de Andres AL, del Barrio JL, de Miguel AG: Coverage and predictors of influenza vaccination among adults with diabetes in Spain. Diabetes Res Clin Pract 2008, 79:510-517.
• [20]Rodríguez-Rieiro C, Domínguez-Berjón MF, Esteban-Vasallo MD, Sánchez-Perruca L, Astray-Mochales J, Fornies DI, Ordoñez DB, Jiménez-García R: Vaccination coverage against 2009 seasonal influenza in chronically ill children and adults: analysis of population registries in primary care in Madrid (Spain). Vaccine 2010, 28:6203-6209.
• [21]Guthmann JP, Bone A, Nicolau J, Lévy-Bruhl D: Insuffisance de couverture vaccinale grippale A(H1N1)2009 en population générale et dans les groupes à risque durant la pandémie 2009–2010 en France. BEHWeb 2010, 3:1-6. http://www.invs.sante.fr/behweb/2010/03/a-1_2.htm webcite
• [22]Partouche H, Benainous O, Barthe J, Pierret J, Rigal L, Michaloux M, Gilberg S: A survey about determinants of 2009 pandemic influenza A(H1N1) vaccination among French general practionners patients. Motivac study Rev Prat 2011, 61:1411-1417.
• [23]Lin Y, Huang L, Nie S, Liu Z, Yu H, Yan W, Xu Y: Knowledge, attitudes and practices (KAP) related to the pandemic (H1N1) 2009 among Chinese general population: a telephone survey. BMC Infect Dis 2011, 11:128. BioMed Central Full Text
• [24]Ormen B, Türker N, Vardar I, Kaptan F, El S, Ural S, Kaya F, Coşkun NA: Attitudes and side effects related to pandemic influenza A (H1N1) vaccination in healthcare personnel. Mikrobiyol Bul 2012, 46:57-64.
• [25]Ahluwalia IB, Singleton JA, Jamieson DJ, Rasmussen SA, Harrison L: Seasonal influenza vaccine coverage among pregnant women: pregnancy risk assessment monitoring system. J Womens Health (Larchmt) 2011, 20:649-651.
• [26]van Lier A, Steens A, Ferreira JA, van der Maas NAT, de Melker HE: Acceptance of vaccination during pregnancy: experience with 2009 influenza A (H1N1) in the Netherlands. Vaccine 2012, 30:2892-2899.
• [27]Blondel B, Mahjoub N, Drewniak N, Launay O, Goffinet F: Failure of the vaccination campaign against A(H1N1) influenza in pregnant women in France: results from a national survey. Vaccine 2012, 30:5661-5665.
• [28]Wallis DH, Chin JL, Sur DKC, Lee MY: Increasing rates of influenza vaccination during pregnancy: a multisite interventional study. J Am Board Fam Med 2006, 19:345-349.
• [29]Gallagher KM, Juhasz M, Harris NS, Teshale EH: Predictors of influenza vaccination in HIV-infected patients in the United States, 1990–2002. J Infect Dis 2007, 196:339-346.
• [30]Cotte L, Voirin N, Richard C, Brochier C, Schlienger I, Lack P, Lina B, Vanhems P, Zoulim F: Factors associated with pandemic influenza A/H1N1 vaccine coverage in a French cohort of HIV-infected patients. Vaccine 2011, 29:5638-5644.
• [31]Vaux S, Van Cauteren D, Guthmann J-P, Le Strat Y, Vaillant V, de Valk H, Lévy-Bruhl D: Influenza vaccination coverage against seasonal and pandemic influenza and their determinants in France: a cross-sectional survey. BMC Public Health 2011, 11:30. BioMed Central Full Text
• [32]Falchi A, Lasserre A, Gallay A, Blanchon T, Sednaoui P, Lassau F: A survey of primary care physician practices in antibiotic prescribing for the treatment of uncomplicated male gonoccocal urethritis. BMC Fam Pract 2011, 12(1):35. BioMed Central Full Text
• [33]Ministère de la Santé, de la Jeunesse, des Sports et de la Vie associative: Plan 2007-2011pour l'amélioration de la qualité de vie des personnes atteintes de maladies chroniques. http://www.sante.gouv.fr/IMG/pdf/plan2007_2011.pdf webcite
• [34]Desoubeaux N, Herbert C, Launoy G, Vallée JP, Bouvier V, Maurel J, Née E, Gignoux M: Mass screening of colorectal cancer by general practitioners in France: what is the real target population? Gastroenterol Clin Biol 1997, 21:760-763.